GO:1990828 hepatocyte dedifferentiation: Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990828 hepatocyte dedifferentiation describes the process by which mature hepatocytes lose their specialized structural and functional features and revert toward a progenitor-like state.
• Inflammatory signals, particularly Kupffer-cell-derived IL-6, can repurpose hepatocytes toward dedifferentiation by activating progenitor genes from injury-specific enhancers.
• CXCR4 has been identified as a driver of hepatocyte reprogramming in alcohol-related liver disease, making it a candidate therapeutic target.
• Yap-Sox9 and Notch-Sox9 signaling axes determine hepatocyte plasticity and lineage-specific hepatocarcinogenesis.
• Hepatocyte dedifferentiation can be profiled using single-cell multi-omics, which reveals heterogeneity and potential maintenance strategies.
• Dedifferentiated hepatocytes can release extracellular vesicles that promote endothelial dedifferentiation in chronic liver disease through a miR-153-3p-pyroptosis axis.
Description
Hepatocyte dedifferentiation (GO:1990828) is a biological process in which specialized epithelial cells of the liver lose the structural or functional features that characterize them in the mature organism, or some other relatively stable phase of the organism's life history. Under certain conditions, these cells can revert back to features of the stem cells that were their ancestors. This process is increasingly recognized as a central mechanism in liver injury, regeneration, and tumorigenesis, and it has become a focus of research because it links chronic inflammation to cellular reprogramming and cancer. Understanding hepatocyte dedifferentiation is critical for developing therapies that target liver disease progression, as dedifferentiated cells can acquire progenitor-like properties that drive fibrosis and hepatocellular carcinoma. Recent studies have identified key signaling pathways and molecular drivers, including IL-6 from Kupffer cells, CXCR4, Yap-Sox9, and Notch-Sox9, that orchestrate this transition. Moreover, single-cell multi-omics approaches have begun to decipher the heterogeneity of dedifferentiated hepatocytes and propose maintenance strategies. This article synthesizes current knowledge on the mechanisms, genes, and research methods associated with GO:1990828, providing a resource for researchers studying liver biology and disease.
hepatocyte dedifferentiation At A Glance
| GO ID | GO:1990828 |
|---|---|
| GO term | hepatocyte dedifferentiation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Loss of mature hepatocyte features and reversion toward a progenitor-like state |
| Associated signaling | IL-6, CXCR4, Yap-Sox9, Notch-Sox9 |
| Disease relevance | Alcohol-related liver disease, hepatocellular carcinoma, chronic liver disease |
| Research methods | Single-cell multi-omics, lineage tracing, enhancer profiling |
What Is GO:1990828?
According to the Gene Ontology, hepatocyte dedifferentiation (GO:1990828) is the process in which a hepatocyte, a specialized epithelial cell of the liver, loses the structural or functional features that characterize it in the mature organism, or some other relatively stable phase of the organism's life history. Under certain conditions, these cells can revert back to the features of the stem cells that were their ancestors. This definition captures the essence of cellular plasticity, where mature hepatocytes can undergo a reprogramming event that diminishes their specialized functions and reacquires progenitor-like characteristics.
Why Is hepatocyte dedifferentiation Important in Cell Biology?
Hepatocyte dedifferentiation is important because it represents a fundamental mechanism of cellular plasticity that underlies liver regeneration, chronic injury, and cancer. In conditions such as alcohol-related liver disease, dedifferentiated hepatocytes acquire progenitor-like traits that contribute to fibrosis and tumorigenesis. The process is driven by inflammatory signals and transcription factors that can be targeted therapeutically, as demonstrated by the identification of CXCR4 as a driver of reprogramming. Moreover, dedifferentiated hepatocytes can influence their microenvironment by releasing extracellular vesicles that promote endothelial dedifferentiation, thereby amplifying liver disease progression. Understanding this process is therefore essential for developing interventions that prevent or reverse pathological cell fate changes in the liver.
• Hepatocyte dedifferentiation is a key driver of alcohol-related liver disease and hepatocellular carcinoma.
• IL-6 from Kupffer cells repurposes hepatocytes toward dedifferentiation via injury-specific enhancers.
• CXCR4 signaling promotes cell reprogramming and is a potential therapeutic target.
• Yap-Sox9 and Notch-Sox9 axes determine hepatocyte plasticity and lineage-specific carcinogenesis.
• Dedifferentiated hepatocytes release extracellular vesicles that induce endothelial dedifferentiation.
• Single-cell multi-omics can decipher heterogeneity and maintenance strategies for dedifferentiated cells.
• The process is relevant to liver regeneration and chronic injury responses.
• It provides a model for studying cellular plasticity and reprogramming in epithelial tissues.
• Understanding dedifferentiation may lead to new biomarkers for early liver disease detection.
• Targeting dedifferentiation pathways could complement existing therapies for liver cancer.
What Happens During hepatocyte dedifferentiation?
Initiation by Inflammatory Signals
In simple terms: Inflammation triggers liver cells to start losing their specialized identity.
Hepatocyte dedifferentiation is often initiated by inflammatory signals in the liver microenvironment. Kupffer-cell-derived IL-6 has been shown to repurpose hepatocytes for dedifferentiation by activating progenitor genes from injury-specific enhancers. This cytokine-mediated activation leads to a transcriptional reprogramming that diminishes mature hepatocyte functions and promotes a progenitor-like state.
Activation of Progenitor Gene Programs
In simple terms: Cells switch on genes that are normally active in stem cells.
Following initiation, dedifferentiating hepatocytes activate progenitor gene programs. This involves the opening of injury-specific enhancers and the expression of genes associated with stemness, such as those regulated by Yap and Sox9. The Notch-Sox9 axis has also been implicated in mediating hepatocyte dedifferentiation in models of hepatocellular carcinoma. These molecular changes lead to loss of mature markers and gain of progenitor markers.
Role of CXCR4 in Reprogramming
In simple terms: A receptor called CXCR4 helps drive the reprogramming process.
CXCR4 has been identified as a driver of cell reprogramming during hepatocyte dedifferentiation in alcohol-related liver disease. Profiling studies show that CXCR4 expression is upregulated in dedifferentiated hepatocytes and that its inhibition can attenuate the dedifferentiation process. This highlights the chemokine signaling axis as a key regulator of hepatocyte plasticity.
Extracellular Vesicle-Mediated Crosstalk
In simple terms: Dedifferentiated cells send signals to other cells via tiny vesicles.
Dedifferentiated hepatocytes can release extracellular vesicles that promote endothelial dedifferentiation in chronic liver disease through the miR-153-3p-pyroptosis axis. This intercellular communication amplifies the dedifferentiation response and contributes to disease progression. The vesicles carry microRNAs that induce pyroptosis in endothelial cells, leading to their dedifferentiation.
Single-Cell Heterogeneity and Maintenance
In simple terms: Not all cells dedifferentiate the same way, and single-cell tools reveal this diversity.
Single-cell multi-omics has deciphered the heterogeneity of hepatocyte dedifferentiation and illuminated maintenance strategies. This approach reveals subpopulations of dedifferentiated cells with distinct molecular signatures and identifies pathways that sustain the dedifferentiated state. Such insights are crucial for developing targeted interventions.
Key Genes Involved in GO:1990828 hepatocyte dedifferentiation
The following genes and proteins have been experimentally implicated in hepatocyte dedifferentiation (GO:1990828) based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL6 | Kupffer-cell-derived cytokine that activates progenitor genes from injury-specific enhancers | Drives dedifferentiation in liver injury models |
| CXCR4 | Chemokine receptor that promotes cell reprogramming | Driver of dedifferentiation in alcohol-related liver disease |
| YAP1 | Transcriptional co-activator that determines hepatocyte plasticity | Yap-Sox9 signaling in hepatocarcinogenesis |
| SOX9 | Transcription factor involved in progenitor identity | Mediates dedifferentiation via Yap and Notch axes |
| NOTCH1 | Signaling receptor that regulates cell fate | Notch-Sox9 axis in zebrafish HCC |
| KRAS | Oncogene that can induce dedifferentiation | Kras(G12V)-induced zebrafish HCC model |
| MIR153-3P | MicroRNA carried by extracellular vesicles | Promotes endothelial dedifferentiation via pyroptosis |
| GSDMD | Pyroptosis executor | Mediates endothelial dedifferentiation downstream of miR-153-3p |
| IL6R | IL-6 receptor | Mediates IL-6 signaling for dedifferentiation |
| STAT3 | Transcription factor downstream of IL-6 | Potential mediator of IL-6-driven dedifferentiation |
| CXCL12 | Ligand for CXCR4 | Chemokine axis in dedifferentiation |
| CTNNB1 | Beta-catenin, involved in Wnt signaling | May contribute to progenitor gene activation |
| AFP | Alpha-fetoprotein, progenitor marker | Marker of dedifferentiated hepatocytes |
| KRT19 | Cytokeratin 19, progenitor marker | Marker of dedifferentiated hepatocytes |
| EPCAM | Epithelial cell adhesion molecule | Progenitor marker in dedifferentiation |
| PROM1 | CD133, stem cell marker | Progenitor marker in dedifferentiation |
| THY1 | CD90, stem cell marker | Progenitor marker in dedifferentiation |
| ALB | Albumin, mature hepatocyte marker | Loss indicates dedifferentiation |
How Is hepatocyte dedifferentiation Regulated?
Hepatocyte dedifferentiation is regulated by a complex network of inflammatory cytokines, chemokines, and transcription factors. IL-6 from Kupffer cells acts as a key initiator by activating progenitor genes from injury-specific enhancers. CXCR4 signaling drives reprogramming in alcohol-related liver disease. The Yap-Sox9 and Notch-Sox9 axes are critical regulators of hepatocyte plasticity and lineage-specific hepatocarcinogenesis. Additionally, extracellular vesicles carrying miR-153-3p can induce endothelial dedifferentiation through pyroptosis, indicating a broader regulatory role in the liver microenvironment. Single-cell multi-omics has revealed heterogeneity in regulatory programs that maintain the dedifferentiated state.
hepatocyte dedifferentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CXCR4 | Alcohol-related liver disease | Knockout or overexpression in hepatocytes |
| YAP1 | Hepatocellular carcinoma | Conditional knockout or knock-in in mouse liver |
| SOX9 | Hepatocarcinogenesis | Lineage tracing and knockout models |
| IL6 | Liver injury and dedifferentiation | Kupffer cell-specific knockout |
| MIR153-3P | Endothelial dedifferentiation in chronic liver disease | Extracellular vesicle transfer experiments |
Alcohol-Related Liver Disease
Hepatocyte dedifferentiation is a hallmark of alcohol-related liver disease, where CXCR4 has been identified as a driver of cell reprogramming. Profiling studies in human samples and mouse models show that dedifferentiated hepatocytes acquire progenitor markers and contribute to disease progression. Targeting CXCR4 or its downstream effectors may offer therapeutic benefits.
Hepatocellular Carcinoma
Dedifferentiation is closely linked to hepatocellular carcinoma (HCC), as Yap-Sox9 signaling determines lineage-specific hepatocarcinogenesis. In zebrafish models, the Notch-Sox9 axis mediates hepatocyte dedifferentiation in Kras(G12V)-induced HCC. These findings suggest that dedifferentiation pathways are oncogenic drivers and potential targets for HCC therapy.
Chronic Liver Disease and Endothelial Dysfunction
In chronic liver disease, hepatocyte-derived extracellular vesicles promote endothelial dedifferentiation through the miR-153-3p-pyroptosis axis. This intercellular crosstalk exacerbates vascular dysfunction and fibrosis. Understanding this mechanism may lead to new strategies to preserve endothelial integrity in liver disease.
From hepatocyte dedifferentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CXCR4 drive hepatocyte dedifferentiation? | CXCR4 knockout or overexpression in hepatocytes |
| What is the role of IL-6 in dedifferentiation? | IL-6 knockout or Kupffer cell-specific deletion |
| How does Yap-Sox9 signaling affect plasticity? | Yap or Sox9 conditional knockout mice |
| Can Notch-Sox9 axis be targeted in HCC? | Zebrafish Kras(G12V) model with Notch inhibition |
| What is the function of miR-153-3p in endothelial dedifferentiation? | Knock-in or knockout of miR-153-3p in hepatocytes |
| How heterogeneous is dedifferentiation? | Single-cell multi-omics in mouse models |
How to Study the hepatocyte dedifferentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Transcriptomic heterogeneity | Identifying dedifferentiated subpopulations |
| Single-cell ATAC-seq | Chromatin accessibility | Mapping regulatory elements in dedifferentiation |
| ChIP-seq | Histone modifications and TF binding | Enhancer profiling for progenitor genes |
| Lineage tracing | Cell fate transitions | Tracking hepatocyte dedifferentiation in vivo |
| Extracellular vesicle isolation | Vesicle cargo and function | Studying intercellular crosstalk |
| Immunofluorescence | Protein expression and localization | Validating markers like AFP, KRT19 |
| Western blot | Protein levels | Quantifying dedifferentiation markers |
| qRT-PCR | Gene expression | Measuring progenitor and mature markers |
Single-Cell Multi-Omics
Single-cell multi-omics combines transcriptomic and epigenomic profiling to decipher hepatocyte dedifferentiation at single-cell resolution. This method reveals heterogeneity in dedifferentiated cell populations and identifies regulatory elements that maintain the dedifferentiated state. It is particularly useful for discovering novel markers and therapeutic targets.
Enhancer Profiling
Enhancer profiling, such as ChIP-seq for histone modifications, can identify injury-specific enhancers that are activated during dedifferentiation. This approach has been used to show that IL-6 activates progenitor genes from such enhancers. It provides insights into the transcriptional regulatory logic of dedifferentiation.
Lineage Tracing
Lineage tracing in mouse models allows researchers to follow the fate of mature hepatocytes as they dedifferentiate. This method has been instrumental in demonstrating that hepatocytes can revert to progenitor-like cells. It can be combined with genetic labeling to track specific subpopulations.
Extracellular Vesicle Analysis
Extracellular vesicle analysis involves isolating vesicles from dedifferentiated hepatocytes and characterizing their cargo, such as miR-153-3p. Functional assays can then test their ability to induce dedifferentiation in target cells. This method is key for understanding intercellular communication in liver disease.
How CRISPR Can Be Used to Study GO:1990828 hepatocyte dedifferentiation
Knockout
CRISPR knockout can be used to delete genes such as CXCR4, IL6, or YAP1 in hepatocytes or liver organoids to test their requirement for dedifferentiation. For example, CXCR4 knockout in hepatocytes can attenuate alcohol-induced dedifferentiation. Knockout models help establish causality and identify therapeutic targets.
Point Mutation
Point mutations can be introduced to mimic activating or inactivating mutations in genes like KRAS or CTNNB1 that are associated with dedifferentiation and cancer. For instance, Kras(G12V) mutation in zebrafish induces HCC with dedifferentiation features. Such models are valuable for studying the contribution of specific mutations to the dedifferentiation process.
Knock-in
Knock-in of reporter genes or tags, such as fluorescent proteins, into endogenous loci like AFP or KRT19 allows real-time tracking of dedifferentiated cells. This approach enables lineage tracing and isolation of dedifferentiated hepatocytes for further analysis. Knock-in of human disease-associated variants can also model genetic susceptibility.
Overexpression
Overexpression of genes such as IL6, CXCR4, or YAP1 in hepatocytes can drive dedifferentiation and accelerate disease phenotypes. This strategy is useful for gain-of-function studies and for generating models of dedifferentiation-associated liver disease. Overexpression can be achieved via CRISPR activation or transgenic constructs.
How EDITGENE Supports hepatocyte dedifferentiation Research
Researchers studying hepatocyte dedifferentiation-related genes often need to determine whether a candidate gene is causally involved in the process, and to dissect its molecular mechanism. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for hepatocyte dedifferentiation research.
Frequently Asked Questions About hepatocyte dedifferentiation
What is hepatocyte dedifferentiation?
Hepatocyte dedifferentiation (GO:1990828) is the process in which a mature hepatocyte loses its specialized structural and functional features and reverts toward a progenitor-like state.
What genes are involved in hepatocyte dedifferentiation?
Key genes include IL6, CXCR4, YAP1, SOX9, NOTCH1, and KRAS, among others.
How is hepatocyte dedifferentiation regulated?
It is regulated by inflammatory signals like IL-6, chemokine signaling via CXCR4, and transcription factors such as Yap and Sox9.
What diseases are associated with hepatocyte dedifferentiation?
It is associated with alcohol-related liver disease, hepatocellular carcinoma, and chronic liver disease.
What methods are used to study hepatocyte dedifferentiation?
Single-cell multi-omics, enhancer profiling, lineage tracing, and extracellular vesicle analysis are commonly used.
What is the role of CXCR4 in hepatocyte dedifferentiation?
CXCR4 drives cell reprogramming in alcohol-related liver disease and is a potential therapeutic target.
How does IL-6 induce hepatocyte dedifferentiation?
Kupffer-cell-derived IL-6 activates progenitor genes from injury-specific enhancers, promoting dedifferentiation.
Can CRISPR be used to study hepatocyte dedifferentiation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are valuable for dissecting gene function in this process.
What are the markers of dedifferentiated hepatocytes?
Markers include AFP, KRT19, EPCAM, PROM1, and THY1, while mature markers like ALB are lost.
What is the clinical relevance of hepatocyte dedifferentiation?
It contributes to liver disease progression and cancer, making it a target for therapeutic intervention.
Conclusion
Hepatocyte dedifferentiation (GO:1990828) is a fundamental biological process that underlies liver regeneration, chronic injury, and cancer. Research has identified key drivers such as IL-6, CXCR4, Yap-Sox9, and Notch-Sox9, and has revealed intercellular crosstalk via extracellular vesicles. Single-cell multi-omics is providing unprecedented insights into the heterogeneity of this process. Targeting dedifferentiation pathways holds promise for treating liver diseases, and continued research using advanced CRISPR models will be essential for translating these findings into therapies.
References
- 1. Li L et al.. 2023. Kupffer-cell-derived IL-6 is repurposed for hepatocyte dedifferentiation via activating progenitor genes from injury-specific enhancers.. Cell Stem Cell 30(3):283-299.e9 PMID: 36787740
- 2. Aguilar-Bravo B et al.. 2023. Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming.. J Hepatol 79(3):728-740 PMID: 37088308
- 3. VanHook AM. 2023. IL-6 drives hepatocyte dedifferentiation.. Sci Signal 16(776):eadh4937 PMID: 36917641
- 4. Liu Y et al.. 2022. Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis.. J Hepatol 76(3):652-664 PMID: 34793870
- 5. Abad-Jordà L et al.. 2026. Hepatocyte-derived extracellular vesicles promote endothelial dedifferentiation in chronic liver disease through the miR-153-3p-pyroptosis axis.. Hepatology 84(1):74-90 PMID: 41072000
- 6. Aguilar-Bravo B et al.. 2023. Hepatocyte Dedifferentiation Profiling In Alcohol-Related Liver Disease Identifies CXCR4 As A Driver Of Cell Reprogramming.. bioRxiv PMID: 37066245
- 7. Sun J et al.. 2022. Notch-Sox9 Axis Mediates Hepatocyte Dedifferentiation in Kras(G12V)-Induced Zebrafish Hepatocellular Carcinoma.. Int J Mol Sci 23(9) PMID: 35563098
- 8. Hao J et al.. 2025. Single-cell multi-omics deciphers hepatocyte dedifferentiation and illuminates maintenance strategies.. Cell Prolif 58(3):e13772 PMID: 39810466
